Efficacy and safety of adeno‐associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy

VandenDriessche, 2003, Gene therapy for the hemophilias, J Thromb Haemost, 1, 1550, 10.1046/j.1538-7836.2003.00265.x

VandenDriessche, 2002, Lentiviral vectors containing the human immunodeficiency virus type‐1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen‐presenting cells in vivo, Blood, 100, 813, 10.1182/blood.V100.3.813

Nakai, 2001, Extrachromosomal recombinant adeno‐associated virus vector genomes are primarily responsible for stable liver transduction in vivo, J Virol, 75, 6969, 10.1128/JVI.75.15.6969-6976.2001

Kay, 2000, Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector, Nat Genet, 24, 257, 10.1038/73464

Manno, 2006, Successful transduction of liver in hemophilia by AAV‐Factor IX and limitations imposed by the host immune response, Nat Med, 12, 342, 10.1038/nm1358

Scallan, 2006, Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice, Blood, 107, 1810, 10.1182/blood-2005-08-3229

Nakai, 2002, A limited number of transducible hepatocytes restricts a wide‐range linear vector dose response in recombinant adeno‐associated virus‐mediated liver transduction, J Virol, 76, 11343, 10.1128/JVI.76.22.11343-11349.2002

Chao, 2000, Several log increase in therapeutic transgene delivery by distinct adeno‐associated viral serotype vectors, Mol Ther, 2, 619, 10.1006/mthe.2000.0219

Gao, 2002, Novel adeno‐associated viruses from rhesus monkeys as vectors for human gene therapy, Proc Natl Acad Sci, 99, 11854, 10.1073/pnas.182412299

Gao, 2004, Clades of Adeno‐associated viruses are widely disseminated in human tissues, J Virol, 78, 6381, 10.1128/JVI.78.12.6381-6388.2004

Gregorevic, 2004, Systemic delivery of genes to striated muscles using adeno‐associated viral vectors, Nat Med, 10, 828, 10.1038/nm1085

Wang, 2005, Adeno‐associated virus serotype 8 efficiently delivers genes to muscle and heart, Nat Biotechnol, 23, 321, 10.1038/nbt1073

Miao, 2000, Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro, Mol Ther, 1, 522, 10.1006/mthe.2000.0075

Niwa, 1991, Efficient selection for high‐expression transfectants with a novel eukaryotic vector, Gene, 108, 193, 10.1016/0378-1119(91)90434-D

Follenzi, 2000, Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV‐1 pol sequences, Nat Genet, 25, 217, 10.1038/76095

Wang, 1997, A factor IX‐deficient mouse model for hemophilia B gene therapy, Proc Natl Acad Sci USA, 94, 11563, 10.1073/pnas.94.21.11563

Arruda, 2001, Lack of germline transmission of vector sequences following systemic administration of recombinant AAV‐2 vector in males, Mol Ther, 4, 586, 10.1006/mthe.2001.0491

Davidoff, 2005, Comparison of the ability of adeno‐associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models, Mol Ther, 11, 875, 10.1016/j.ymthe.2004.12.022

Nakai, 2005, Unrestricted hepatocyte transduction with adeno‐associated virus serotype 8 vectors in mice, J Virol, 79, 214, 10.1128/JVI.79.1.214-224.2005

Sarkar, 2006, Long‐term efficacy of adeno‐associated virus serotypes 8 and 9 in hemophilia a dogs and mice, Hum Gene Ther, 17, 427, 10.1089/hum.2006.17.427

Nathwani, 2006, Self‐complementary adeno‐associated virus vectors containing a novel liver‐specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver, Blood, 107, 2653, 10.1182/blood-2005-10-4035

Mingozzi, 2003, Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer, J Clin Invest, 111, 1347, 10.1172/JCI200316887

Dobrzynski, 2006, Prevention of cytotoxic T lymphocyte responses to factor IX‐expressing hepatocytes by gene transfer‐induced regulatory T cells, Proc Natl Acad Sci USA, 103, 4592, 10.1073/pnas.0508685103

Vandenberghe, 2006, Heparin binding directs activation of T cells against adeno‐associated virus serotype 2 capsid, Nat Med, 12, 967, 10.1038/nm1445

Thomas, 2004, Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno‐associated virus vectors, J Virol, 78, 3110, 10.1128/JVI.78.6.3110-3122.2004

Lozier, 1999, Adenovirus‐mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose‐limiting toxicity, Blood, 94, 3968, 10.1182/blood.V94.12.3968.424k43_3968_3975

Matsui, 2003, Targeting ischemic cardiac dysfunction through gene transfer, Curr Atheroscler Rep, 5, 191, 10.1007/s11883-003-0023-0

Arruda, 2004, Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno‐associated viral vector serotype 1, Blood, 103, 85, 10.1182/blood-2003-05-1446

Gao, 2006, Biology of AAV serotype vectors in liver‐directed gene transfer to nonhuman primates, Mol Ther, 13, 77, 10.1016/j.ymthe.2005.08.017

Jiang, 2006, Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs, Blood, 108, 107, 10.1182/blood-2005-12-5115